Asian American and Pacific Islander men are the most likely, and whites the least likely, to survive five years after a diagnosis of distant (advanced) prostate cancer, according to new data from 2011-2016 released by the Centers for Disease Control and Prevention (CDC).
After the diagnosis of advanced prostate cancer, 42% of Asian Americans and Pacific Islanders survive for at least 5 years compared with 39% of American Indians and Alaska Natives, 38% of Hispanics, 33% of Blacks, and 31% of whites.
About three-quarters of U.S. men with prostate cancer have low-risk, localized cancer at diagnosis and essentially all men survive this at least five years. Even with a diagnosis of regional prostate cancer, 97% to 99% of all men survive 5 years.
However, the percent of men with distant, advanced cancer at diagnosis has doubled to 8% since 2003 and survival for at least 5 years drops to 31% to 42%.
Localized prostate cancer is confined to the prostate; regional prostate cancer extends to adjacent organs or structures or spreads to regional lymph nodes; distant prostate cancer has spread to parts of the body remote from the prostate.
See “Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017” on the CDC website (October 16, 2020)